The retinoids, a class ofpolyisoprenoids including retinol and retinoic acid, exhibit strong cell-differentiating and morphogenic potential (1-4). For example, retinoic acid or retinol induces a granulocytic phenotype in HL-60 cells (4) and neuronal development in human embryonal carcinoma cells (5) and modulates the morphogenesis of axolotl limb buds (6, 7). The biochemical systems through which retinoids appear to effect morphogenesis and/or cytodifferentiation are: (i) the modulation of a guanine nucleotide-binding proteindependent pathway and (ii) the coordinate regulation of the expression of homeobox gene clusters (8-12). Retinoid function is supported by three distinct groups of proteins whose names are indicated by the specificity of the retinoid ligand: (i) cellular retinol-binding protein I (cRBP) and cellular retinoic acid-binding protein (cRABP); (ii) a membraneassociated protein, mRABP; and (iii) human nuclear retinoic acid receptors (hnRARs) (refs. 13-15; also see ref. 1 for a review). hnRAR-like proteins initially characterized in rat testes interstitial cells (16) are found exclusively in the cell nucleus. Two analogous human proteins, hnRAR-a and hnRAR-P, recently have been cloned and characterized (14, 15). These two hnRAR sequences are distinct transcripts and exhibit a high degree (260%) of primary structural homology with the progesterone and estrogen receptors and with the hepatocellular carcinoma-specific steroid hormone receptor (14, 15, 17) .
The retinoids, a class ofpolyisoprenoids including retinol and retinoic acid, exhibit strong cell-differentiating and morphogenic potential (1) (2) (3) (4) . For example, retinoic acid or retinol induces a granulocytic phenotype in HL-60 cells (4) and neuronal development in human embryonal carcinoma cells (5) and modulates the morphogenesis of axolotl limb buds (6, 7) . The biochemical systems through which retinoids appear to effect morphogenesis and/or cytodifferentiation are: (i) the modulation of a guanine nucleotide-binding proteindependent pathway and (ii) the coordinate regulation of the expression of homeobox gene clusters (8) (9) (10) (11) (12) . Retinoid function is supported by three distinct groups of proteins whose names are indicated by the specificity of the retinoid ligand: (i) cellular retinol-binding protein I (cRBP) and cellular retinoic acid-binding protein (cRABP); (ii) a membraneassociated protein, mRABP; and (iii) human nuclear retinoic acid receptors (hnRARs) (refs. [13] [14] [15] ; also see ref. 1 for a review). hnRAR-like proteins initially characterized in rat testes interstitial cells (16) are found exclusively in the cell nucleus. Two analogous human proteins, hnRAR-a and hnRAR-P, recently have been cloned and characterized (14, 15) . These two hnRAR sequences are distinct transcripts and exhibit a high degree (260%) of primary structural homology with the progesterone and estrogen receptors and with the hepatocellular carcinoma-specific steroid hormone receptor (14, 15, 17) .
The role ofthe cytoplasmic retinoid-binding proteins in the transduction ofa retinoid signal and the integration of hnRAR with retinoid-specific cell programs in normal or malignant cells remains undetermined. Using antisense oligodeoxynucleotides [oligo(dN)s] to the start codon and 12 bases sequentially upstream in the mRNAs for both human cRBP (18) and hnRAR (a-type; refs. 14 and 15), we treated human malignant keratinocytes with the oligo(dN)s and measured: (i) the levels of cRBP and hnRAR, (ii) the ability of retinol to specifically induce the target gene alkaline phosphatase (19) , and (iii) the effect of down regulation of cRBP and hnRAR on the clonogenic potential of human malignant keratinocytes. Our results show that oligo(dN)s down-regulate both of these classes of proteins in these cells. Moreover, the loss of either receptor class blocks retinoid-dependent induction of alkaline phosphatase and alters the retinoid-dependent morphology and clonogenic potential of these antisense-treated cells.
MATERIALS AND METHODS
Chemicals.
[3H]Retinoic acid (48 Ci/mmol; 1 Ci = 37 GBq) and [3H]retinol (36 Ci/mmol) were gifts of DuPont. Unlabeled retinoic acid and retinol were purchased from Sigma and purified by reverse-phase HPLC as described (20) . Oligo(dN)s complementary to or of exact sequence to cRBP and hnRAR were prepared with the following sequences as described (14, 18, 21) : sense cRBP = 5'-GTCACTCCCG-AAATG-3', antisense cRBP = 5'-CATTTCGGGAGTGAC-3', and antisense hnRAR = 5'-CATGCCAAGCGGCCA-3'.
Cell Culture. Malignant human keratinocytes, SCC-25, were obtained from the American Type Culture Collection (CRL 1628) . Early passage stock cultures were grown as described (22) . The cultures were shown to be free of mycoplasma contamination by the fluorescence staining method of Chen (23) . One hour prior to exposure of the cells to oligo(dN)s, the fetal bovine serum-containing medium was removed, and cells were washed three times with 5 ml of phosphate-buffered saline (0.05 M phosphate buffer/0.85% NaCl solution, pH 7.2). The cultures were then refed fresh serum-free MCDB 153 medium supplemented with 5 ,ug of insulin per ml, 10 ng of epidermal growth factor per ml, and 0.5% bovine pituitary extract (22) . The designated oligo (dN) in 50 ,ul of 0.85% NaCl solution at pH 7.4 was added at the concentrations indicated.
Retinoid Receptor Assay. The cold acetone binding procedure of Ashendel and Boutwell (24) hnRAR based on their ligand binding and selective extraction from cytosolic and nuclear fractions, respectively (16, 25, 26) . Briefly, 2-5 x 107 SCC-25 cells were dispersed in 500 ILI of 25 mM KCI/25 mM Tris HCl, pH 7.8. This suspension was sonicated, the disrupted cells were centrifuged for 6 x 106 gmin, and the cytoplasmic fraction (supernatant) was removed. The tubes containing this fraction were then placed on ice and exposed to long-wave UV light (340 nm, 10 W at 15 cm) for 2 hr to remove endogenous retinoids. The cytoplasmic fraction (250 ,ul) was then assayed as described (24) .
Preliminary tests of this assay produced Kd values of 6.1 x 10-9 M and 4.7 x 10-9 M for cRBP and cRABP, respectively.
The assay for hnRAR was accomplished as described above with the following modifications. The 6 x 106 g-min pellet from the cells was washed three times with 250 /ul of cell suspension buffer. The nuclei were sedimented and saltextracted as detailed (26) . The final 0.4 M NaCl fraction was assayed for hnRAR as described above. The Kd value of retinoic acid for hnRAR was determined to be 7.8 x 10-9 M. Cell Clonal Growth Assay and Viability. After treatment with oligo(dN)s, cells were removed from the initial treatment dishes and replated. Conditions for this experiment are described in Table 2 . Other Methods. Alkaline phosphatase (EC 3.1.3.1) was assayed by the method of Reese et al. (27) , and protein was determined by the method of Bradford (28) .
RESULTS
Time-Course Effect of Antisense Oligo(dN)s. The direct addition of oligo(dN)s to cell culture media and their uptake and the regulation of target proteins have been described (29) (30) (31) . We show in Fig. 1 An approximate half-life value, til2, for cRBP and hnRAR of 1-1.5 hr was calculated from the above data.
Effect of Oligo(dN) Concentration on Retinoid Receptor Levels. To determine the optimal concentration and specificity of the oligo(dN)s that resulted in a loss of either cRBP or hnRAR, we tested both antisense oligo(dN)s in the concentration range of 0.5-40 ,uM, a sense/antisense doublestrand hybrid, and DNase-treated oligo(dN) controls. Fig. 3 indicates that antisense cRBP oligo(dN) effectively reduced cytoplasmic cRBP by 70-92% in a concentration range of 10-40 p.M over a 4.5-hr treatment period; the levels of hnRAR were not changed by this treatment. Sense cRBP oligo(dN) did not significantly affect the cRBP level in the cytoplasmic fraction. Moreover, the level of cRBP in the cytoplasmic fraction was not reduced in cells treated with antisense cRBP oligo(dN) hybridized to the complementary sense oligo(dN), nor was this antisense oligo(dN) effective when treated with DNase, whereas the efficacy of 30 p.M antisense cRBP oligo(dN) pretreated with inactivated DNase was not diminished.
Similarly, antisense hnRAR reduced (>90%) the level of nuclear hnRAR (Fig. 4) , whereas antisense cRBP oligo(dN) had no effect on the level of this receptor. 16 -hr incubation assay of cytoplasm for cRBP; and , no treatment with 16hr incubation assay of nucleus for hnRAR. At the end of the treatment periods, the cells were assayed as described in the legend to Fig. 1 Concentration-dependent effect of antisense cRBP and antisense hnRAR oligo(dN)s on nuclear levels of hnRAR in human malignant keratinocytes. Cells were grown as described; the nuclear pellet fraction was assayed for hnRAR as described in the legend to We questioned whether the observed changes in cell morphology induced by antisense oligo(dN) treatments resulted in a cell viability-dependent receptor loss. The viability of cultures after exposure to the oligo(dN)s was not significantly reduced at the end of the 3.75-hr treatment period (Table 2 ). In contrast, clonal growth of cells treated with either antisense cRBP or antisense hnRAR (Table 2) and replated in either serum-containing or serum-free medium was reduced by .83% when compared with sense cRBPtreated cells or untreated controls. The choice of medium for replating was a determinant, however, in the final colony count, where the presence of serum in the medium increased clonogenic potential by '100%. In addition, Table 2 shows that by stringently washing antisense oligo(dN)-treated cells with serum-free medium at time points up to 1.75 hr after antisense oligo(dN) exposure, there was no loss of clonogenic potential. However, when the antisense oligo(dN) treatment period was >2.75 hr, washing was ineffective in preventing the loss of clonogenic potential. Moreover, when cell rounding was induced by using cytochalasin B or when cell stasis was induced in these cells with 0.05% NaN3, no change in cRBP, cRABP, or hnRAR levels was observed (data not shown), further suggesting that the effect of the oligo(dN)s was specific and not the result of simple cytokinetic of cytostatic phenomena.
DISCUSSION
Our results strongly support the conclusion that antisense oligo(dN)s constructed to portions of the 5' untranslated regions of human cRBP and hnRAR mRNAs specifically down-regulate their respective retinoid receptor levels in a human malignant keratinocyte cell line. Moreover, each the end of the induction period, the treatment medium was removed, the cells were washed three times with 5 ml of ice-cold 0.85% NaCl solution (pH 7.2) and resuspended in 250,ul of AP assay buffer (50 mM Tris HCI/2 mM Mg2+, pH 9.7). The cell suspension was sonicated at a setting of 40 with a Sonic Sonifier for 20 sec on ice, followed by centrifugation for 8 x 103 g-min. AP was assayed in 50-100 Al ofthe supernatant fraction by using 6 mM p-nitrophenyl phosphate substrate in a 2.0-ml reaction volume (27) . Additionally, the oligonucleotide listed (30 uM) or the vehicle was added to the cell culture 90 min prior to retinol treatment. The cells were incubated in the dark at 37°C for 3.5 hr. The retinol exposure period was terminated by the aspiration of the treatment medium and washing of the cells as described above.
tValues were obtained by treatment of cells with the optimum level of retinol (5 uM) and are the means ± SD of three replicate determinations.
receptor class is down-regulated independently in the absence of exogenous ligands to those receptors. Corresponding to the loss of either receptor class is the loss of retinolinducible alkaline phosphatase, a gene product shown to be under de novo regulation by retinoids (19, 27, 32) . The selection of retinol for the induction of alkaline phosphatase addresses the possible irreversible oxidation of retinol to retinoic acid in these cells. Involvement of this metabolic pathway may be required for the ultimate transduction of the retinoid signal cascade and may involve interaction between cRBP with hnRAR or either receptor acting alone. In fact, the apparent differential morphological effect of antisense cRBP oligo(dN) versus antisense hnRAR may be evidence to such pathway divergences. Conversely, one may predict the operation of nuclear receptors for retinol whose function is consolidated with hnRAR, also accounting for the differential morphogenic response or that hnRAR requires both retinol and retinoic acid for modifying its interaction with chromatin. Whether alkaline phosphatase expression is an integral part of the retinoid signal cascade and thus, necessary for maintenance of the differentiated state of cells remains to be determined.
Our results also indicate that clonal growth of human malignant keratinocytes requires sustained levels of both the cytoplasmic and nuclear retinoid receptors. We estimate from the above data that the criticaIlevel ofreceptors is about 20-25% that of untreated cells after a >2.75-hr exposure period beyond which a cell commitment pathway is induced (apoptosis), which ultimately results in irreversible terminal differentiation and/or cell death (33) .
Previously, we reported that the response of Chinese hamster lung cells to retinoids was composed of at least two distinct phases, an immediate signal transduction or primaryresponse phase, coupled with a later cell-commitment phase. The primary-response phase appeared to occur within 5 min when these cells are exposed to physiological levels of either retinol (1 AM) or retinoic acid (5 nM). This phase was marked by changes in the accumulation (400%) of inositol tetraphosphate, phosphorylation of nucleolin, and a sensitivity to guanine nucleotide-binding protein inhibitors (10) (11) (12) . We have shown in this study that cRBP and probably cRABP, compartmentalized in the cytoplasm, do not just constitute a shuttle system for retinol (or retinoic acid) but are intimately involved with or are component features of a retinoiddependent cell maintenance system, as evidenced by cRBP down-regulation and the resulting refractoriness of malignant human keratinocyte cells to retinol-dependent induction of tSubconfluent (70-80%o confluent) cultures ofcells were treated as described with 40,M oligo(dN) or received no treatment.
At the end of the 3.75-hr treatment period, cells were washed three times with 5 ml of isotonic saline (pH 7.4); cells were removed from the dish by using 20 mM EDTA/0.5% trypsin in Eagle's balanced salt solution. The cell suspension was centrifuged for 3 x 103 gmin, and the supernatant was aspirated from the vial. The cells were washed twice with complete MCDB 153 medium containing 10%o fetal bovine serum, counted, and plated with this medium in a 60-mm Falcon dish at a density of 3000 cells per dish. The cells were cultured for 7 days, rinsed with isotonic saline (pH 7.4), fixed in the dish with 5% formaldehyde, and stained with 0.2% crystal violet (22) . The colonies were counted by using an automated Artek model 870 colony counter set for colony inclusion at more than seven cells per colony. The "No treatment" control value (1.00) = 610 + 3 colonies per dish.
tThe protocol for these cells was as above. However, at a time point of 3.75 hr of treatment, the oligo(dN) was washed out of the dish by using three 5-ml portions of basal MCDB 153 medium without serum. The cells were incubated an additional 2.0 hr in the oligo(dN)-free medium, removed from the plate, replated, and terminated at 7 days; colonies were counted as described above. The "No treatment" control value (1.00) = 298 ± 9 colonies per dish. §The protocol for these cells was as described immediately above. However, at a time point of 1.75 hr of treatment, the oligo(dN) was washed out of the dish by using three 5-ml portions of basal MCDB 153 medium without serum. The cells were incubated an additional 2.0 hr in the oligo(dN)-free medium, removed from the plate, replated, and terminated at 7 days; colonies were counted as described above. The "No treatment" control value (1.00) = 250 ± 20 colonies per dish. (35) . However, we saw little modulation of cRBP or cRABP receptors with antisense hnRAR oligo(dN) or of hnRAR with antisense cRBP oligo(dN) in the absence of exogenous ligand. Thus, in malignant cells such as SCC-25, cytoplasmic and/or nuclear receptors for retinoids may be part of the same gene or homeobox set, or perhaps their protein levels are not correlated with their expression in homeobox subsets.
Finally, there are strong implications from our data on the role of retinoids in the process of carcinogenesis. Retinoids are particularly potent antipromoting agents (36) . They are antagonists to both the phorbol ester-type tumor promoters as well as the non-phorbol-ester-type tumor promoters (e.g., okadaic acid) (31) (32) (33) 36) . Recent data also show that retinoids are highly effective against initiating agents such as dimethylbenz[a]anthracene (37 This work was supported by National Cancer Institute Grant RO1 CA40894 (to F.O.C.) and Grant P01 CA34968 (to J.J.W.).
